Expression of SGLT1 in Human Hearts and Impairment of Cardiac Glucose Uptake by Phlorizin during Ischemia-Reperfusion Injury in Mice.
Sodium-glucose cotransporter 1 (SGLT1) is thought to be expressed in the heart as the dominant isoform of cardiac SGLT, although more information is required to delineate the subtypes of SGLTs in human hearts. Moreover, the functional role of SGLTs in the heart remains to be fully elucidated. We her...
Main Authors: | Yusuke Kashiwagi, Tomohisa Nagoshi, Takuya Yoshino, Toshikazu D Tanaka, Keiichi Ito, Tohru Harada, Hiroyuki Takahashi, Masahiro Ikegami, Ryuko Anzawa, Michihiro Yoshimura |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4486720?pdf=render |
Similar Items
-
Exogenous ANP Treatment Ameliorates Myocardial Insulin Resistance and Protects against Ischemia–Reperfusion Injury in Diet-Induced Obesity
by: Yuhei Oi, et al.
Published: (2022-07-01) -
Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury.
by: Yoon-Kyung Chang, et al.
Published: (2016-01-01) -
Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice
by: David-Silva A, et al.
Published: (2020-03-01) -
URAT1 is expressed in cardiomyocytes and dotinurad attenuates the development of diet-induced metabolic heart disease
by: Yoshiro Tanaka, et al.
Published: (2023-09-01) -
Effects of angiotensin receptor‐neprilysin inhibitor on insulin resistance in patients with heart failure
by: Yusuke Kashiwagi, et al.
Published: (2023-06-01)